Skip to content

Intravenous Dexmedetomidine on Inflammatory Mediators in Patients candidate of Surgery

Effect of Intravenous Dexmedetomidine on Inflammatory factors in Patients undergoing Total Abdominal Hysterectomy

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180506039558N1
Enrollment
40
Registered
2018-07-28
Start date
2018-07-23
Completion date
Unknown
Last updated
2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Hysterectomy.

Interventions

Intervention 1: Intervention group: In the case group, immediately after the induction, Dexmedetomidine with a bolus dose of (1 µg/kg) during 15 minutes and infusion with a dose of (0.5 µg/kg) will be

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 65 Years

Inclusion criteria

Inclusion criteria: Female candidate of Total Abdominal Hysterectomy (TAH) Body mass index (BMI): 18 to 40 kg/m2 American Society of Anesthesiologists (ASA) classification I , II

Exclusion criteria

Exclusion criteria: Allergic reaction to Dexmedetomidine History of Dexmedetomidine administration over the past week History of heart, lung, liver, and kidney diseases Patients with neurological or neuromuscular disorders Patients with anemia or bleeding disorders Consumption of Alcohol, narcotic and Antipsychotic medications Patients with diabetes

Design outcomes

Primary

MeasureTime frame
Quantitative evaluation of C- Reactive Protein. Timepoint: 30 minutes before anesthesia induction (Before intervention), 1 hour after the start of operation, Immediately, 6 and 24 hours after the completion of the operation. Method of measurement: Blood test.;Quantitative evaluation of ESR. Timepoint: 30 minutes before anesthesia induction (Before intervention), 1 hour after the start of operation, Immediately, 6 and 24 hours after the completion of the operation. Method of measurement: Blood test.;Quantitative evaluation of Leukocytosis. Timepoint: 30 minutes before anesthesia induction (Before intervention), 1 hour after the start of operation, Immediately, 6 and 24 hours after the completion of the operation. Method of measurement: Blood test.;Quantitative evaluation of Blood Glucose. Timepoint: 30 minutes before anesthesia induction (Before intervention), 1 hour after the start of operation, Immediately, 6 and 24 hours after the completion of the operation. Method of measurement: Blood test.;Mean arterial pressure. Timepoint: Before anesthesia induction (Before intervention), after intubation, every 15 minutes until the end of the recovery period. Method of measurement: Gauge pressure.;Heart rate. Timepoint: Before anesthesia induction (Before intervention), after intubation, every 15 minutes until the end of the recovery period. Method of measurement: Electrocardiograph.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Derakhshani

Ahvaz University of Medical Sciences

derakhshani.m@ajums.ac.ir+98 61329235893

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026